secwatch.observer — SEC 8-K summary
======================================

Issuer:     GLAUKOS Corp (GKOS)
CIK:        0001192448
Form:       8-K
Filed at:   2025-04-30T23:59:59+00:00
Accession:  0001558370-25-005999
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Glaukos Q1 net sales record $106.7M (+25% YoY); net loss narrows to $0.32/sh from $0.82
--------------------------------------------------------------------------------

- Record Q1 net sales $106.7M, up 25% reported and 26% constant currency vs $85.6M last year.
- U.S. Glaucoma sales $59.1M (+41% YoY); total Glaucoma $88.1M (+31% YoY).
- GAAP net loss $18.1M ($0.32/sh) vs $40.8M ($0.82/sh) in Q1 2024; non-GAAP net loss $12.6M ($0.22).
- Gross margin ~77%; non-GAAP gross margin ~82%; operating loss improved to $20.7M from $39.1M.
- Reaffirmed FY 2025 net sales guidance of $475M-$485M; cash $303.4M with no debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1192448/000155837025005999/0001558370-25-005999-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1192448/000155837025005999/gkos-20250430x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-005999

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer